OBIO

NASDAQ open

Orchestra BioMed Holdings

6.57 USD
▼-0.43-6.14%
盘后 5.00 0.00%
2026-11-20
市值
$517.88M
市盈率
—
EPS
-0.92
股息率
—
52 周区间
3.46 – 7.83
成交量
249.08K
Beta
0.55
目标价
13.29
52W 低 3.4652W 高 7.83
价格走势

公司简介

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company’s flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications, such as urology or osteoarthritis; and CNT-HF, a b...